
Since 2004, the Republic of Iraq has undertaken a concerted effort to comply with all of its international obligations to prevent the proliferation and the use of chemical, biological, radiological, and nuclear (CBRN) weapons. A centerpiece of this effort is Iraq’s development of a National Biorisk Management System. The Iraqi National Monitoring Authority (INMA), which is responsible for CBRN security and non-proliferation in Iraq, has played a key role in establishing this system. This article provides an overview of Iraq’s international non-proliferation commitments, describes the legal and organizational steps it has taken to implement these commitments, and examines current initiatives to strengthen Iraq’s biosecurity.
070, Global health, global health, Biodefense, Biosafety, biorisk, Public health, biodefense, Biorisk, public health, biosafety, Bioterrorism, Biosecurity, Iraq, Bioengagement, bioengagement, Public Health, Public aspects of medicine, RA1-1270, biosecurity
070, Global health, global health, Biodefense, Biosafety, biorisk, Public health, biodefense, Biorisk, public health, biosafety, Bioterrorism, Biosecurity, Iraq, Bioengagement, bioengagement, Public Health, Public aspects of medicine, RA1-1270, biosecurity
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
